Growth Metrics

Novartis Ag (NVS) Shares Outstanding (Weighted Average) (2016 - 2026)

Novartis Ag's Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $736000.0 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 40218579134.97% to $736000.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $736000.0 billion, a 40218579134.97% increase, with the full-year FY2025 number at $1.9 billion, down 100.0% from a year prior.
  • Shares Outstanding (Weighted Average) hit $736000.0 billion in Q1 2026 for Novartis Ag, down from $766000.0 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NVS hit a ceiling of $901000.0 billion in Q1 2022 and a floor of $1.1 million in Q2 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $572294.2 billion across 5 years, with a median of $766000.0 billion in 2025.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 100.0% in 2023 and later skyrocketed 71441441341.44% in 2024.
  • Tracing NVS's Shares Outstanding (Weighted Average) over 5 years: stood at $890.0 million in 2022, then decreased by 7.3% to $825.0 million in 2023, then soared by 96121112.12% to $793000.0 billion in 2024, then decreased by 3.4% to $766000.0 billion in 2025, then dropped by 3.92% to $736000.0 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NVS at $736000.0 billion in Q1 2026, $766000.0 billion in Q4 2025, and $766000.0 billion in Q3 2025.